GSK Consumer Healthcare appoints new head for South East Asia

Debjit Rudra joins as General Manager for the South East Asia area and member of the Asia Middle East Africa leadership team.

Issued: Singapore

GlaxoSmithKline (GSK) Consumer Healthcare today announced the recent appointment of Debjit Rudra as General Manager South East Asia. Debjit will oversee GSK’s consumer healthcare business across South East Asia, reporting directly to Zubair Ahmed who heads the Asia Middle East Africa region.

Debjit joins GSK from Unilever, where he held key positions in sales, marketing and senior regional leadership roles during his 22-year tenure. Most recently, Debjit assumed the role of Asia Vice President of Unilever’s Household Care division, playing a central role in the development and implementation of Unilever’s strategic roadmap for the category across Asia and ANZ.

Commenting on the latest addition to his team, Zubair Ahmed said: “With more than 20 years of global commercial experience and a proven track record of success, Debjit brings the industry and leadership experience to achieve our growth ambitions for South East Asia. His experience of driving strategy and delivering significant commercial growth will be of great value as we continue to grow our innovative brands that consumers love.”

Debjit Rudra said: “GSK Consumer Healthcare is one of the largest consumer health companies in South East Asia, comprising some of the world’s most powerful and trusted brands. These brands epitomise the values of GSK and have made a real and positive difference to consumers’ lives in the region. I am excited to join the business at this time, particularly given the opportunity presented by the GSK-Novartis joint venture to accelerate growth across the region.”

Based in Singapore, Debjit’s appointment is effective immediately.

GSK
One of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com.

Media enquiries

GSK

Sharon Mak

DD: +6 03 7491 2103
M: +6 012 200 6249

Sharon.sm.mak@gsk.com

Ogilvy Public Relations

Janice Wong

DD: +65 6213 7857
M: +65 9622 9510

Janice.wong@ogilvy.com

 

Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.D 'Risk factors' in the company's Annual Report on Form 20-F for 2013.